Session moderated by BBMRI.pl will discuss the challenges connected with the access to medical data used in scientific research and the introduction of personalised therapies.

• Why is the access to medical data in biobanking, personalized medicine and biotechnology industry necessary?
• Who is the owner of medical data of patients collected by public institutions?
• What are the barriers in collecting medical data by individuals, scientific institutions and innovative entities operating on the health sector?
• Can digital transformation in healthcare influence the access to medical data and how it can contribute to the development of science and the biotechnology industry?